Haskell-Luevano C - Search Results

1

Novel agouti-related-protein-based melanocortin-1 receptor antagonist.

Thirumoorthy R, Holder JR, Bauzo RM, Richards NG, Edison AS, Haskell-Luevano C. Thirumoorthy R, et al. J Med Chem. 2001 Nov 22;44(24):4114-24. doi: 10.1021/jm010215z. J Med Chem. 2001. PMID: 11708914

2

Topographical modification of melanotropin peptide analogues with beta-methyltryptophan isomers at position 9 leads to differential potencies and prolonged biological activities.

Haskell-Luevano C, Boteju LW, Miwa H, Dickinson C, Gantz I, Yamada T, Hadley ME, Hruby VJ. Haskell-Luevano C, et al. J Med Chem. 1995 Nov 10;38(23):4720-9. doi: 10.1021/jm00023a012. J Med Chem. 1995. PMID: 7473600

3

Design, synthesis, biology, and conformations of bicyclic alpha-melanotropin analogues.

Haskell-Luevano C, Shenderovich MD, Sharma SD, Nikiforovich GV, Hadley ME, Hruby VJ. Haskell-Luevano C, et al. J Med Chem. 1995 May 12;38(10):1736-50. doi: 10.1021/jm00010a018. J Med Chem. 1995. PMID: 7752197

4

Binding and cAMP studies of melanotropin peptides with the cloned human peripheral melanocortin receptor, hMC1R.

Haskell-Luevano C, Miwa H, Dickinson C, Hruby VJ, Yamada T, Gantz I. Haskell-Luevano C, et al. Biochem Biophys Res Commun. 1994 Nov 15;204(3):1137-42. doi: 10.1006/bbrc.1994.2581. Biochem Biophys Res Commun. 1994. PMID: 7980588

5

Characterizations of the unusual dissociation properties of melanotropin peptides from the melanocortin receptor, hMC1R.

Haskell-Luevano C, Miwa H, Dickinson C, Hadley ME, Hruby VJ, Yamada T, Gantz I. Haskell-Luevano C, et al. J Med Chem. 1996 Jan 19;39(2):432-5. doi: 10.1021/jm950407s. J Med Chem. 1996. PMID: 8558511

6

The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors.

Boteju LW, Nikiforovich GV, Haskell-Luevano C, Fang SN, Zalewska T, Stropova D, Yamamura HI, Hruby VJ. Boteju LW, et al. J Med Chem. 1996 Sep 27;39(20):4120-4. doi: 10.1021/jm960078j. J Med Chem. 1996. PMID: 8831778

7

Truncation studies of alpha-melanotropin peptides identify tripeptide analogues exhibiting prolonged agonist bioactivity.

Haskell-Luevano C, Sawyer TK, Hendrata S, North C, Panahinia L, Stum M, Staples DJ, Castrucci AM, Hadley MF, Hruby VJ. Haskell-Luevano C, et al. Peptides. 1996;17(6):995-1002. doi: 10.1016/0196-9781(96)00141-6. Peptides. 1996. PMID: 8899819

8

Three-dimensional molecular models of the hMC1R melanocortin receptor: complexes with melanotropin peptide agonists.

Haskell-Luevano C, Sawyer TK, Trumpp-Kallmeyer S, Bikker JA, Humblet C, Gantz I, Hruby VJ. Haskell-Luevano C, et al. Drug Des Discov. 1996 Dec;14(3):197-211. Drug Des Discov. 1996. PMID: 9017363

9

Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.

Haskell-Luevano C, Nikiforovich G, Sharma SD, Yang YK, Dickinson C, Hruby VJ, Gantz I. Haskell-Luevano C, et al. J Med Chem. 1997 May 23;40(11):1738-48. doi: 10.1021/jm960845e. J Med Chem. 1997. PMID: 9171884

10

Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R.

Haskell-Luevano C, Hendrata S, North C, Sawyer TK, Hadley ME, Hruby VJ, Dickinson C, Gantz I. Haskell-Luevano C, et al. J Med Chem. 1997 Jul 4;40(14):2133-9. doi: 10.1021/jm960840h. J Med Chem. 1997. PMID: 9216831

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results